These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23302345)

  • 1. [Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1].
    Fan XS; Wang SA
    Zhonghua Bing Li Xue Za Zhi; 2012 Nov; 41(11):779-83. PubMed ID: 23302345
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloid neoplasms associated with eosinophilia and rearrangement of PDGFRA, PDGFRB, and FGFR1: a review.
    Savage N; George TI; Gotlib J
    Int J Lab Hematol; 2013 Oct; 35(5):491-500. PubMed ID: 23489324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1.
    Patterer V; Schnittger S; Kern W; Haferlach T; Haferlach C
    Ann Hematol; 2013 Jun; 92(6):759-69. PubMed ID: 23400675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1.
    Bain BJ
    Haematologica; 2010 May; 95(5):696-8. PubMed ID: 20442440
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloid neoplasms with eosinophilia.
    Reiter A; Gotlib J
    Blood; 2017 Feb; 129(6):704-714. PubMed ID: 28028030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid neoplasm with prominent eosinophilia and PDGFRA rearrangement treated with imatinib mesylate.
    Rathe M; Kristensen TK; Møller MB; Carlsen NL
    Pediatr Blood Cancer; 2010 Oct; 55(4):730-2. PubMed ID: 20589620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid/lymphoid neoplasm associated with eosinophilia and concurrent rearrangement of PDGFRA and FGFR1: A very rare pediatric case.
    Wang B; Wang X; Lin J; Zhang Y; Gan W; Li T
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30507. PubMed ID: 37336772
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular genetic characterization of myeloid/lymphoid neoplasms associated with eosinophilia and rearrangement of
    Baer C; Muehlbacher V; Kern W; Haferlach C; Haferlach T
    Haematologica; 2018 Aug; 103(8):e348-e350. PubMed ID: 29567772
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2.
    Pozdnyakova O; Orazi A; Kelemen K; King R; Reichard KK; Craig FE; Quintanilla-Martinez L; Rimsza L; George TI; Horny HP; Wang SA
    Am J Clin Pathol; 2021 Feb; 155(2):160-178. PubMed ID: 33367495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic myeloid disorders.
    Noel P
    Semin Hematol; 2012 Apr; 49(2):120-7. PubMed ID: 22449622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of cytogenetics and molecular biology in patients with eosinophilia].
    Qu SQ; Ai XF; Li CW; Li QH; Xu ZF; Qin TJ; Zhang Y; Xiao ZJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1216-20. PubMed ID: 23114151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal mast cells in myeloid neoplasm with eosinophilia and PDGFRB rearrangement.
    Bourrienne MC; Debus J
    Blood; 2019 Aug; 134(8):718. PubMed ID: 31439618
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematological disorders and hypereosinophilias].
    Malfuson JV; Fagot T; Konopacki J; Mangouka L; Souleau B; de Revel T
    Rev Med Interne; 2009 Apr; 30(4):322-30. PubMed ID: 19201511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders.
    Cross NC; Reiter A
    Acta Haematol; 2008; 119(4):199-206. PubMed ID: 18566537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGFRA rearrangement leading to hyper-eosinophilia, T-lymphoblastic lymphoma, myeloproliferative neoplasm and precursor B-cell acute lymphoblastic leukemia.
    Huang Q; Snyder DS; Chu P; Gaal KK; Chang KL; Weiss LM
    Leukemia; 2011 Feb; 25(2):371-5. PubMed ID: 21304535
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular drug targets in myeloproliferative neoplasms: mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1.
    Tefferi A
    J Cell Mol Med; 2009 Feb; 13(2):215-37. PubMed ID: 19175693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myeloproliferative neoplasms and related diseases].
    Kirito K
    Rinsho Ketsueki; 2009 Mar; 50(3):134-46. PubMed ID: 19352079
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.
    Erben P; Gosenca D; Müller MC; Reinhard J; Score J; Del Valle F; Walz C; Mix J; Metzgeroth G; Ernst T; Haferlach C; Cross NC; Hochhaus A; Reiter A
    Haematologica; 2010 May; 95(5):738-44. PubMed ID: 20107158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloproliferative neoplasm with eosinophilia and PDGFR beta rearrangement in an infant.
    Palla S; Boddu D; Matthew LG; Janet NB; Geevar T
    Pediatr Blood Cancer; 2023 Jan; 70(1):e29856. PubMed ID: 35713205
    [No Abstract]   [Full Text] [Related]  

  • 20. Eosinophilia in Hematologic Disorders.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):439-52. PubMed ID: 26209894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.